|Articles|September 1, 2012
- Pharmaceutical Executive-09-01-2012
- Volume 0
- Issue 0
Pharmaceutical Executive Digital Edition - September 2012
Busting the Tape
Advertisement
Articles in this issue
over 13 years ago
Pharm Exec's 11th Annual Industry Auditover 13 years ago
Patients Wade Into the Pricing Debateover 13 years ago
The Endless Treadmill of End-of-Life Careover 13 years ago
The Power of Patient Feedbackover 13 years ago
The Payer C Change: From Customers to Competitorsover 13 years ago
The Margin Callover 13 years ago
Open Innovation in Pharma: Defining the DialogueNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Lilly Reduces Price of Zepbound Single-Dose Vials for Self-Pay Patients
2
Report: FDA to Change Vaccine Approval Process Based on Agency’s Claim of Covid Vaccine-Related Deaths
3
Korea and Australia's P&MA Shift: From Local Launch Opportunities to Regional Blueprint
4
Pharmaceutical Executive Daily: U.S. & U.K. Agree to 0% Tariffs on Pharmaceutical Products
5
